Skip to content
    AI Vendor Pulse · Issue 16

    The Blueprint Goes Agentic — AI in Protocol Design & Trial Simulation

    Open the PDFOpen on LinkedIn

    Sign in to LinkedIn, then select Subscribe.

    Summary

    An executive read on five vendors rebuilding protocol design and trial simulation with AI — QuantHealth for in-silico trial simulation and Katina protocol scoring, Biorce for the Aika protocol-design platform after its Series A, Faro for structured, machine-readable protocols and its Bristol Myers Squibb system-of-record collaboration, Cytel for adaptive-design statistics with East Horizon and an AI code assistant, and Evinova, AstraZeneca's Study Designer platform, now partnering with Astellas, Bristol Myers Squibb and Merck KGaA.

    For market education, not a buying recommendation. The full issue is in the PDF.

    Choosing between vendors like these?

    Vendor advisory looks at workflow fit, vendor evidence, enterprise readiness and regulated-use controls.

    Not sure where to start?

    The AI assessment helps you pick the workflows worth changing first. See selected work for what that looks like.

    The Pulses

    Stay close to what’s changing.

    AI Vendor Pulse and AI Pharma Pulse, published on LinkedIn.

    About 1,070 newsletter subscribers · October 2026

    AI Vendor Pulse

    Mondays

    Open on LinkedIn

    AI Pharma Pulse

    Fridays

    Open on LinkedIn

    To subscribe, sign in to LinkedIn and select Subscribe on the newsletter page.